Management of Bone Metastases 2018
DOI: 10.1007/978-3-319-73485-9_9
|View full text |Cite
|
Sign up to set email alerts
|

Metastases to the Long Bones: Algorithm of Treatment

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
18
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(19 citation statements)
references
References 66 publications
1
18
0
Order By: Relevance
“…The bone cement is the most popular material for replacing excised bone tissue for several reasons. Among its benefits are: enhanced structural stability, rapid recovery and better local control after curettage due to its thermic characteristic [36,37]. The drawbacks are longer prolonged surgery, a risk of wound healing disorders and local bleeding.…”
Section: Surgical Treatmentmentioning
confidence: 99%
See 3 more Smart Citations
“…The bone cement is the most popular material for replacing excised bone tissue for several reasons. Among its benefits are: enhanced structural stability, rapid recovery and better local control after curettage due to its thermic characteristic [36,37]. The drawbacks are longer prolonged surgery, a risk of wound healing disorders and local bleeding.…”
Section: Surgical Treatmentmentioning
confidence: 99%
“…Using the bone cement requires the use of PMMA (PolyMethyl MethAcrylate) of low viscosity, applied under minimal pressure. A proper level of patient hydration is also important -it reduces the risk of fat embolisms [37]. Using an intramedullary nail also has its limitations.…”
Section: Surgical Treatmentmentioning
confidence: 99%
See 2 more Smart Citations
“…Additionally, the literature shows that patients with a single bone metastasis should be treated radically, similar to patients with primary bone tumors, rather than receive palliative treatment only [ 6 ]. This is seen especially in the case of metastases of clear cell carcinoma of the kidney, where the longer survival of patients undergoing radical treatment has been achieved [ 11 , 12 ]. Nevertheless, each case of a patient with MBD should be evaluated individually within the group of oncologists, radiotherapists, and orthopedists.…”
Section: Introductionmentioning
confidence: 99%